As of July 2026, 1 paid clinical trial is testing Empagliflozin in Denison, Texas. Trials typically compensate participants for time, travel, and study visits, and many also provide study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Denison, TX at 16 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Texas Oncology - Northeast Texas | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 5 |
| Soma Clinical Trials | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 4 |
| Texas Oncology-Northeast Texas | Breast Cancer, Breast Neoplasms, Non-Small Cell Lung Cancer Metastatic | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Premier Pulmonary Critical Care and Sleep Medicine | Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF) | 2 |
| Texama Medical Center | Heart Failure, Obesity | 2 |
| ACCOMPLISH-1 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| CON-10304, Denison, TX | Heart Failure | 1 |
| FIN-10404, Denison, TX | Heart Failure | 1 |
| GSK Investigational Site | Scleroderma, Systemic, Systemic Sclerosis Associated Interstitial Lung Disease | 1 |
| Investigative | Solid Tumors | 1 |
| Premier Pulmonary Critical Care and Sleep | Chronic Obstructive Pulmonary Disease | 1 |
| Texas Oncology - Denison - 1139 | Non Small Cell Lung Cancer | 1 |
| Texas Oncology Northeast Texas | Myelodysplastic Syndromes | 1 |
| Texoma Liver Center | Alpha1-Antitrypsin Deficiency | 1 |
| USOR - Texas Oncology Northeast Texas - Denison | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
Recruiting trials in Denison grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 31 recruiting clinical trials in Denison, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Denison compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Denison include Heart Failure (4), Advanced Non-Small Cell Lung Cancer (2), Breast Cancer (2), Liver Fibrosis (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Denison on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Denison include Texas Oncology - Northeast Texas, Soma Clinical Trials, Texas Oncology-Northeast Texas, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Denison are Cancer & tumors (8), Diabetes & metabolic (4), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.